Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.
Clinical trial NCT05734040 · COMPLETED
Trial details
- NCT number
- NCT05734040
- Sponsor
- Osivax
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2023-08-10
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.